149 related articles for article (PubMed ID: 36192340)
1. Prevention of post-operative recurrence of Crohn's disease among patients with prior anti-TNFα failure: A retrospective multicenter study.
Le Cosquer G; Altwegg R; Rivière P; Bournet B; Boivineau L; Poullenot F; Bozon A; Buscail L; Laharie D; Gilletta C
Dig Liver Dis; 2023 Jun; 55(6):727-734. PubMed ID: 36192340
[TBL] [Abstract][Full Text] [Related]
2. Anti-TNF Agents and New Biological Agents (Vedolizumab and Ustekinumab) in the Prevention and Treatment of Postoperative Recurrence After Surgery in Crohn's Disease.
Gisbert JP; Chaparro M
Drugs; 2023 Sep; 83(13):1179-1205. PubMed ID: 37505446
[TBL] [Abstract][Full Text] [Related]
3. Previous Exposure to Multiple Anti-TNF Is Associated with Decreased Efficiency in Preventing Postoperative Crohn's Disease Recurrence.
Collins M; Sarter H; Gower-Rousseau C; Koriche D; Libier L; Nachury M; Cortot A; Zerbib P; Blanc P; Desreumaux P; Colombel JF; Peyrin-Biroulet L; Pineton de Chambrun G
J Crohns Colitis; 2017 Mar; 11(3):281-288. PubMed ID: 27578800
[TBL] [Abstract][Full Text] [Related]
4. Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA Registry.
Cañete F; Mañosa M; Casanova MJ; González-Sueyro RC; Barrio J; Bermejo F; Nos P; Iglesias-Flores E; García-Planella E; Pérez-Calle JL; Vicente R; Vera M; Ramos L; Rivero M; De Francisco R; Montserrat A; Benítez O; Navarro P; Taxonera C; Hinojosa E; Márquez-Mosquera L; Navarro-Llavat M; Ramírez-de la Piscina P; Gomollón F; Rodríguez-Alonso L; Núñez-Alonso A; Fernández-Salazar L; Almela P; Ríos León R; De Castro L; Gisbert JP; Ricart E; Cabré E; Domènech E;
Inflamm Bowel Dis; 2019 Oct; 25(11):1862-1870. PubMed ID: 31006801
[TBL] [Abstract][Full Text] [Related]
5. Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease.
Buisson A; Nancey S; Manlay L; Rubin DT; Hebuterne X; Pariente B; Fumery M; Laharie D; Roblin X; Bommelaer G; Pereira B; Peyrin-Biroulet L; Vuitton L;
United European Gastroenterol J; 2021 Jun; 9(5):552-560. PubMed ID: 33951350
[TBL] [Abstract][Full Text] [Related]
6. Anti -TNFα agents in preventing the postoperative recurrence of Crohn's disease: Do they still play a role in the biological era?
Liu C; Li N; Zhan S; Tian Z; Wu D; Li T; Zeng Z; Zhuang X
Expert Opin Biol Ther; 2021 Nov; 21(11):1509-1524. PubMed ID: 34350811
[TBL] [Abstract][Full Text] [Related]
7. Anti-TNFα agents are the best choice in preventing postoperative Crohn's disease: A meta-analysis.
Erős A; Farkas N; Hegyi P; Szabó A; Balaskó M; Veres G; Czakó L; Bajor J; Alizadeh H; Rakonczay Z; Mikó A; Habon T; Erőss B; Bérczi B; Sarlós P
Dig Liver Dis; 2019 Aug; 51(8):1086-1095. PubMed ID: 31278016
[TBL] [Abstract][Full Text] [Related]
8. Adalimumab versus infliximab in treating post-operative recurrence of Crohn's disease: a national cohort study.
Preda CM; Fulger LE; Negreanu L; Manuc M; Sandra I; Diculescu MM
Rev Esp Enferm Dig; 2016 Oct; 108(10):642-647. PubMed ID: 27651132
[TBL] [Abstract][Full Text] [Related]
9. Antitumor Necrosis Factor Agents to Treat Endoscopic Postoperative Recurrence of Crohn's Disease: A Nationwide Study With Propensity-Matched Score Analysis.
Cañete F; Mañosa M; Pérez-Martínez I; Barreiro-de Acosta M; González-Sueyro RC; Nos P; Iglesias-Flores E; Gutiérrez A; Bujanda L; Gordillo J; Ríos León R; Casanova MJ; Villoria A; Rodríguez-Lago I; López Serrano P; García-Herola A; Ramírez-de la Piscina P; Navarro-Llavat M; Taxonera C; Barrio J; Ramos L; Navarro P; Benítez-Leiva O; Calafat M; Domènech E;
Clin Transl Gastroenterol; 2020 Aug; 11(8):e00218. PubMed ID: 32955190
[TBL] [Abstract][Full Text] [Related]
10. Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot study.
Papamichael K; Archavlis E; Lariou C; Mantzaris GJ
J Crohns Colitis; 2012 Oct; 6(9):924-31. PubMed ID: 22424843
[TBL] [Abstract][Full Text] [Related]
11. Early Initiation of Antitumor Necrosis Factor Therapy Reduces Postoperative Recurrence of Crohn's Disease Following Ileocecal Resection.
Axelrad JE; Li T; Bachour SP; Nakamura TI; Shah R; Sachs MC; Chang S; Hudesman DP; Holubar SD; Lightner AL; Barnes EL; Cohen BL; Rieder F; Esen E; Remzi F; Regueiro M; Click B
Inflamm Bowel Dis; 2023 Jun; 29(6):888-897. PubMed ID: 35905032
[TBL] [Abstract][Full Text] [Related]
12. Direct retrospective comparison of adalimumab and infliximab in preventing early postoperative endoscopic recurrence after ileocaecal resection for crohn's disease: results from the MULTIPER database.
Kotze PG; Yamamoto T; Danese S; Suzuki Y; Teixeira FV; de Albuquerque IC; Saad-Hossne R; de Barcelos IF; da Silva RN; da Silva Kotze LM; Olandoski M; Sacchi M; Yamada A; Takeuchi K; Spinelli A
J Crohns Colitis; 2015 Jul; 9(7):541-7. PubMed ID: 25820017
[TBL] [Abstract][Full Text] [Related]
13. Ustekinumab and vedolizumab for the prevention of postoperative recurrence of Crohn's disease: Results from the ENEIDA registry.
Mañosa M; Fernández-Clotet A; Nos P; Martín-Arranz MD; Manceñido N; Carbajo A; Hinojosa E; Hernández-Camba A; Muñoz-Pérez R; Boscá-Watts M; Calvo M; Sierra-Ausín M; Sánchez-Rodríguez E; Barreiro-de Acosta M; Núñez-Alonso A; Zabana Y; Márquez L; Gisbert JP; Guardiola J; Sáinz E; Delgado-Guillena P; Busquets D; van Domselaar M; Girona E; Lorente R; Casas-Deza D; Huguet JM; Maestro S; Cabello MJ; Castro J; Iborra M; Cañete F; Calafat M; Domènech E;
Dig Liver Dis; 2023 Jan; 55(1):46-52. PubMed ID: 35948459
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study.
Yanai H; Kagramanova A; Knyazev O; Sabino J; Haenen S; Mantzaris GJ; Mountaki K; Armuzzi A; Pugliese D; Furfaro F; Fiorino G; Drobne D; Kurent T; Yassin S; Maharshak N; Castiglione F; de Sire R; Nardone OM; Farkas K; Molnar T; Krznaric Z; Brinar M; Chashkova E; Livne Margolin M; Kopylov U; Bezzio C; Bar-Gil Shitrit A; Lukas M; Chaparro M; Truyens M; Nancey S; Lobaton T; Gisbert JP; Saibeni S; Bacsúr P; Bossuyt P; Schulberg J; Hoentjen F; Viganò C; Palermo A; Torres J; Revés J; Karmiris K; Velegraki M; Savarino E; Markopoulos P; Tsironi E; Ellul P; Calviño Suárez C; Weisshof R; Ben-Hur D; Naftali T; Eriksson C; Koutroubakis IE; Foteinogiannopoulou K; Limdi JK; Liu E; Surís G; Calabrese E; Zorzi F; Filip R; Ribaldone DG; Snir Y; Goren I; Banai-Eran H; Broytman Y; Amir Barak H; Avni-Biron I; Ollech JE; Dotan I; Aharoni Golan M
J Crohns Colitis; 2022 Dec; 16(12):1882-1892. PubMed ID: 35895074
[TBL] [Abstract][Full Text] [Related]
15. Colonoscopy-guided therapy for the prevention of post-operative recurrence of Crohn's disease.
Candia R; Bravo-Soto GA; Monrroy H; Hernandez C; Nguyen GC
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD012328. PubMed ID: 32746500
[TBL] [Abstract][Full Text] [Related]
16. Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study.
Kennedy NA; Heap GA; Green HD; Hamilton B; Bewshea C; Walker GJ; Thomas A; Nice R; Perry MH; Bouri S; Chanchlani N; Heerasing NM; Hendy P; Lin S; Gaya DR; Cummings JRF; Selinger CP; Lees CW; Hart AL; Parkes M; Sebastian S; Mansfield JC; Irving PM; Lindsay J; Russell RK; McDonald TJ; McGovern D; Goodhand JR; Ahmad T;
Lancet Gastroenterol Hepatol; 2019 May; 4(5):341-353. PubMed ID: 30824404
[TBL] [Abstract][Full Text] [Related]
17. Adalimumab for maintenance of remission in Crohn's disease.
Townsend CM; Nguyen TM; Cepek J; Abbass M; Parker CE; MacDonald JK; Khanna R; Jairath V; Feagan BG
Cochrane Database Syst Rev; 2020 May; 5(5):CD012877. PubMed ID: 32413933
[TBL] [Abstract][Full Text] [Related]
18. Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients.
Aguas M; Bastida G; Cerrillo E; Beltrán B; Iborra M; Sánchez-Montes C; Muñoz F; Barrio J; Riestra S; Nos P
World J Gastroenterol; 2012 Aug; 18(32):4391-8. PubMed ID: 22969204
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor necrosis factor agents reduce corticosteroid use compared with azathioprine in patients with Crohn's disease.
Kane SV; Jaganathan S; Bedenbaugh AV; Palmer L; Schwartz DA
Curr Med Res Opin; 2014 Sep; 30(9):1821-6. PubMed ID: 24884302
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis.
Singh S; Murad MH; Fumery M; Sedano R; Jairath V; Panaccione R; Sandborn WJ; Ma C
Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):1002-1014. PubMed ID: 34688373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
